Portland, OR, March 03, 2020 (GLOBE NEWSWIRE) -- The Protein Sequencing Industry garnered $5.39 billion in 2018, and is estimated to generate $9.92 billion by 2026, growing at a CAGR of 7.8% from 2019 to 2026.
Prime determinants of growth
Increase in focus on target-based drug development and advancements in analytical techniques & mass spectrometry drive the global protein sequencing market. However, scarcity of skilled labor and laboratory professionals hinders the market growth. On the other hand, untapped potential in computational proteomics create new opportunities in the market.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5633
The Edman degradation segment to maintain its lead position during the forecast period
Based on technology, the Edman degradation segment accounted for nearly three-fifths of the total market share of the global protein sequencing market in 2018, and is estimated to maintain its lead position during the forecast period. This is due to surge in usage of the technique to decode peptide sequences. However, the mass spectrometry segment is expected to maintain the highest CAGR of 8.5% from 2019 to 2026, owing to its ability to offer rapid, accurate sequencing in lesser time.
The reagents & consumables segment to contribute the highest share by 2026
Based on product & services, the reagents & consumables segment accounted for the highest market share in the global protein sequencing market, contributing to nearly three-fifths of the total market share in 2018, and is estimated to contribute the highest share in terms of revenue during the forecast period. This is due to increase in usage of different types of kits, reagents, and others to carry out protein sequencing. However, the protein sequencing services segment is expected to register the highest CAGR of 8.3% from 2019 to 2026. This is attributed to surge in usage for research and development activities.
North America to dominate in terms of revenue throughout the forecast period
Based on region, North America held the largest market share based on revenue, accounting for nearly one-third of the global protein sequencing market in 2018, and is expected to dominate throughout the forecast period. This is due to technological advancements in sequencing platforms and rise in implementation of protein sequencing in this region. However, Asia-Pacific is expected to contribute the highest CAGR of 9.2% from 2019 to 2026, owing to rise in awareness and surge in demand for protein sequencing.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5633
Leading market players
- Bioinformatics Solutions Inc.
- Charles River Laboratories
- Agilent Technologies, Inc.
- Proteome Factory
- Rapid Novor Inc.
- Selvita
- SGS
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Similar Reports:
DNA sequencing Market: Global Opportunity Analysis and Industry Forecast, 2019-2026
Electrocardiograph (ECG) Market: Global Opportunity Analysis and Industry Forecast, 2019-2026
NGS Market: Global Opportunity Analysis and Industry Forecast, 2019-2026
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.